552 related articles for article (PubMed ID: 25007370)
1. Can pityriasis versicolor be treated with 2% ketoconazole foam?
Cantrell WC; Elewksi BE
J Drugs Dermatol; 2014 Jul; 13(7):855-9. PubMed ID: 25007370
[TBL] [Abstract][Full Text] [Related]
2. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor.
Gold MH; Bridges T; Avakian E; Plaum S; Pappert EJ; Fleischer AB; Hardas B
Skinmed; 2011; 9(5):283-6. PubMed ID: 22165042
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study.
Draelos ZD; Feldman SR; Butners V; Alió Saenz AB
J Drugs Dermatol; 2013 Jan; 12(1):e1-6. PubMed ID: 23377341
[TBL] [Abstract][Full Text] [Related]
4. Flutrimazole shampoo 1% versus ketoconazole shampoo 2% in the treatment of pityriasis versicolor. A randomised double-blind comparative trial.
Rigopoulos D; Gregoriou S; Kontochristopoulos G; Ifantides A; Katsambas A
Mycoses; 2007 May; 50(3):193-5. PubMed ID: 17472615
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor.
Gobbato AA; Babadópulos T; Gobbato CA; Ilha Jde O; Gagliano-Jucá T; De Nucci G
Expert Opin Investig Drugs; 2015; 24(11):1399-407. PubMed ID: 26419668
[TBL] [Abstract][Full Text] [Related]
6. Fluconazole versus ketoconazole in the treatment of tinea versicolor.
Farschian M; Yaghoobi R; Samadi K
J Dermatolog Treat; 2002 Jun; 13(2):73-6. PubMed ID: 12060505
[TBL] [Abstract][Full Text] [Related]
7. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
Yazdanpanah MJ; Azizi H; Suizi B
Mycoses; 2007 Jul; 50(4):311-3. PubMed ID: 17576325
[TBL] [Abstract][Full Text] [Related]
8. Tinea versicolor in dark-skinned individuals.
Kallini JR; Riaz F; Khachemoune A
Int J Dermatol; 2014 Feb; 53(2):137-41. PubMed ID: 24320140
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study.
Di Fonzo EM; Martini P; Mazzatenta C; Lotti L; Alvino S
Mycoses; 2008 Nov; 51(6):532-5. PubMed ID: 18422916
[TBL] [Abstract][Full Text] [Related]
10. [A double-blind placebo-controlled study of a 2 percent foaming lotion of ketoconazole in a single application in the treatment of pityriasis versicolor].
Rekacewicz I; Guillaume JC; Benkhraba F; Archimbaud A; Baspeyras M; Boitier F; Bussière M; Coin A; Di Crezenzo MC; Duval J
Ann Dermatol Venereol; 1990; 117(10):709-11. PubMed ID: 2073061
[TBL] [Abstract][Full Text] [Related]
11. Tinea versicolor: treatment and prophylaxis with monthly administration of ketoconazole.
Rausch LJ; Jacobs PH
Cutis; 1984 Nov; 34(5):470-1. PubMed ID: 6094116
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor.
Köse O; Bülent Taştan H; Riza Gür A; Kurumlu Z
J Dermatolog Treat; 2002 Jun; 13(2):77-9. PubMed ID: 12060506
[TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of combination treatment with ketoconazole 2% cream and adapalene 0.1% gel in pityriasis versicolor.
Shi TW; Zhang JA; Tang YB; Yu HX; Li ZG; Yu JB
J Dermatolog Treat; 2015 Apr; 26(2):143-6. PubMed ID: 24802530
[TBL] [Abstract][Full Text] [Related]
14. Ketoconazole--an effective treatment for disseminated pityriasis versicolor.
Schewach-Millet M; Kahana M; Levy A; Yaron-Schiffer O; Sommer B; Shalish L
Isr J Med Sci; 1984 May; 20(5):417-9. PubMed ID: 6088425
[TBL] [Abstract][Full Text] [Related]
15. Ketoconazole 2% shampoo in the treatment of tinea versicolor: a multicenter, randomized, double-blind, placebo-controlled trial.
Lange DS; Richards HM; Guarnieri J; Humeniuk JM; Savin RC; Reyes BA; Hickman J; Pariser DM; Pariser RJ; Sherertz EF; Grossman RM; Gisoldi EM; Klausner MA
J Am Acad Dermatol; 1998 Dec; 39(6):944-50. PubMed ID: 9843006
[TBL] [Abstract][Full Text] [Related]
16. Pityriasis versicolor alba.
Thoma W; Krämer HJ; Mayser P
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):147-52. PubMed ID: 15752280
[TBL] [Abstract][Full Text] [Related]
17. A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
Elewski BE; Abramovits W; Kempers S; Schlessinger J; Rosen T; Gupta AK; Abraham S; Rowell R
J Drugs Dermatol; 2007 Oct; 6(10):1001-8. PubMed ID: 17966177
[TBL] [Abstract][Full Text] [Related]
18. Hyperkeratotic head and neck Malassezia dermatosis.
Boralevi F; Marco-Bonnet J; Lepreux S; Buzenet C; Couprie B; Taïeb A
Dermatology; 2006; 212(1):36-40. PubMed ID: 16319472
[TBL] [Abstract][Full Text] [Related]
19. [A therapeutic trial of oral ketoconazole in the treatment of pityriasis versicolor].
Fenniche S; Haouet S; Ben Osman A
Tunis Med; 1995; 73(6-7):259-62. PubMed ID: 9506175
[No Abstract] [Full Text] [Related]
20. Roles of adapalene in the treatment of pityriasis versicolor.
Shi TW; Ren XK; Yu HX; Tang YB
Dermatology; 2012; 224(2):184-8. PubMed ID: 22572567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
